Netupitant is an antiemetic medication. In the United States, the combinations of netupitant/palonosetron and the prodrug fosnetupitant/palonosetron (both...
10 KB (669 words) - 12:38, 5 August 2024
Netupitant/palonosetron, sold under the brand name Akynzeo, is a fixed-dose combination medication used for the prevention of acute and delayed chemotherapy-induced...
10 KB (547 words) - 05:29, 6 July 2024
Pharma as of 2019. Activase (alteplase), for heart attacks. Akynzeo (netupitant/palonosetron), for nausea and vomiting, licensed by Eisai Co. and Helsinn...
56 KB (5,124 words) - 17:16, 10 August 2024
Health Organization's List of Essential Medicines. The oral combination netupitant/palonosetron is approved for both acute and delayed CINV. The most common...
15 KB (1,212 words) - 16:50, 6 July 2024
S2CID 76202219. "Vogalib". www.rxreasoner.com. Shirley, Matt (July 2021). "Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting". Drugs...
21 KB (1,991 words) - 13:15, 2 March 2024
treatment of chemotherapy-induced nausea and vomiting. It is a prodrug of netupitant. It is used in combination with palonosetron hydrochloride and formulated...
6 KB (230 words) - 07:13, 31 July 2024
(INN) netivudine (INN) netobimin (INN) netoglitazone (USAN) Netromycin netupitant (USAN) Neulasta (Amgen, Inc) Neumega (Genetics Institute, Inc) Neupogen...
5 KB (316 words) - 04:07, 14 August 2024
L-733,060 L-741,671 L-743,310 L-758,298 Lanepitant LY-306740 Maropitant Netupitant NKP-608 Nolpitantium besilate Orvepitant Rolapitant RP-67580 SDZ NKT 343...
20 KB (1,764 words) - 00:16, 29 July 2024
in both acute and especially in delayed phases of emesis. Casopitant, netupitant and rolapitant are some newer additions in this group. Rolapitant has...
29 KB (3,270 words) - 03:23, 5 December 2023
L-733,060 L-741,671 L-743,310 L-758,298 Lanepitant LY-306740 Maropitant Netupitant NKP-608 Nolpitantium besilate Orvepitant Rolapitant RP-67580 SDZ NKT 343...
48 KB (5,337 words) - 03:27, 22 July 2024
L-733,060 L-741,671 L-743,310 L-758,298 Lanepitant LY-306740 Maropitant Netupitant NKP-608 Nolpitantium besilate Orvepitant Rolapitant RP-67580 SDZ NKT 343...
23 KB (2,210 words) - 13:48, 3 June 2024
L-733,060 L-741,671 L-743,310 L-758,298 Lanepitant LY-306740 Maropitant Netupitant NKP-608 Nolpitantium besilate Orvepitant Rolapitant RP-67580 SDZ NKT 343...
6 KB (248 words) - 19:49, 20 December 2023
L-733,060 L-741,671 L-743,310 L-758,298 Lanepitant LY-306740 Maropitant Netupitant NKP-608 Nolpitantium besilate Orvepitant Rolapitant RP-67580 SDZ NKT 343...
4 KB (223 words) - 19:10, 4 January 2024
L-733,060 L-741,671 L-743,310 L-758,298 Lanepitant LY-306740 Maropitant Netupitant NKP-608 Nolpitantium besilate Orvepitant Rolapitant RP-67580 SDZ NKT 343...
17 KB (1,279 words) - 05:53, 10 June 2024
are also used to prevent nausea and vomiting caused by chemotherapy. Netupitant has recently been approved by USFDA. It has also been marketed in combination...
22 KB (2,404 words) - 02:48, 4 September 2023
L-733,060 L-741,671 L-743,310 L-758,298 Lanepitant LY-306740 Maropitant Netupitant NKP-608 Nolpitantium besilate Orvepitant Rolapitant RP-67580 SDZ NKT 343...
21 KB (2,390 words) - 04:36, 13 August 2024
L-733,060 L-741,671 L-743,310 L-758,298 Lanepitant LY-306740 Maropitant Netupitant NKP-608 Nolpitantium besilate Orvepitant Rolapitant RP-67580 SDZ NKT 343...
11 KB (868 words) - 07:12, 14 March 2024
L-733,060 L-741,671 L-743,310 L-758,298 Lanepitant LY-306740 Maropitant Netupitant NKP-608 Nolpitantium besilate Orvepitant Rolapitant RP-67580 SDZ NKT 343...
7 KB (491 words) - 15:12, 3 December 2023
L-733,060 L-741,671 L-743,310 L-758,298 Lanepitant LY-306740 Maropitant Netupitant NKP-608 Nolpitantium besilate Orvepitant Rolapitant RP-67580 SDZ NKT 343...
11 KB (983 words) - 02:47, 26 January 2023
L-733,060 L-741,671 L-743,310 L-758,298 Lanepitant LY-306740 Maropitant Netupitant NKP-608 Nolpitantium besilate Orvepitant Rolapitant RP-67580 SDZ NKT 343...
4 KB (226 words) - 19:23, 6 September 2022
L-733,060 L-741,671 L-743,310 L-758,298 Lanepitant LY-306740 Maropitant Netupitant NKP-608 Nolpitantium besilate Orvepitant Rolapitant RP-67580 SDZ NKT 343...
15 KB (1,716 words) - 22:29, 25 June 2024
L-733,060 L-741,671 L-743,310 L-758,298 Lanepitant LY-306740 Maropitant Netupitant NKP-608 Nolpitantium besilate Orvepitant Rolapitant RP-67580 SDZ NKT 343...
27 KB (2,873 words) - 05:48, 13 February 2024
L-733,060 L-741,671 L-743,310 L-758,298 Lanepitant LY-306740 Maropitant Netupitant NKP-608 Nolpitantium besilate Orvepitant Rolapitant RP-67580 SDZ NKT 343...
4 KB (273 words) - 11:29, 23 January 2023
L-733,060 L-741,671 L-743,310 L-758,298 Lanepitant LY-306740 Maropitant Netupitant NKP-608 Nolpitantium besilate Orvepitant Rolapitant RP-67580 SDZ NKT 343...
5 KB (177 words) - 22:44, 5 March 2022
L-733,060 L-741,671 L-743,310 L-758,298 Lanepitant LY-306740 Maropitant Netupitant NKP-608 Nolpitantium besilate Orvepitant Rolapitant RP-67580 SDZ NKT 343...
4 KB (237 words) - 11:28, 23 January 2023
L-733,060 L-741,671 L-743,310 L-758,298 Lanepitant LY-306740 Maropitant Netupitant NKP-608 Nolpitantium besilate Orvepitant Rolapitant RP-67580 SDZ NKT 343...
3 KB (116 words) - 22:17, 3 December 2023
L-733,060 L-741,671 L-743,310 L-758,298 Lanepitant LY-306740 Maropitant Netupitant NKP-608 Nolpitantium besilate Orvepitant Rolapitant RP-67580 SDZ NKT 343...
5 KB (240 words) - 16:08, 21 August 2022
L-733,060 L-741,671 L-743,310 L-758,298 Lanepitant LY-306740 Maropitant Netupitant NKP-608 Nolpitantium besilate Orvepitant Rolapitant RP-67580 SDZ NKT 343...
3 KB (145 words) - 22:44, 5 March 2022
though development was ultimately discontinued after a related drug netupitant was deemed to be more suitable for clinical development. Befetupitant...
3 KB (164 words) - 06:47, 3 December 2023
L-733,060 L-741,671 L-743,310 L-758,298 Lanepitant LY-306740 Maropitant Netupitant NKP-608 Nolpitantium besilate Orvepitant Rolapitant RP-67580 SDZ NKT 343...
8 KB (955 words) - 23:37, 9 March 2024